Announcements Trials
Browse Landscape

Status

Completed 8Terminated 4Recruiting 4Active not recruiting 3Unknown 2No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Pancreatic Neoplasms 5Gastrointestinal Stromal Tumors 5Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Liver Neoplasms 4Ovarian Neoplasms 2Melanoma 2Cholangiocarcinoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Prostatic Neoplasms 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Meningeal Neoplasms 1Medulloblastoma 1Liver Diseases 1Liver Cirrhosis 1Klatskin Tumor 1Hepatoblastoma 1Hepatitis D 1Hepatitis B 1

Interventions

Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Uveal Melanoma × Gastrointestinal × Clear all
NCT01728051 2013-10-23

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Delcath Systems Inc.

No longer available
DermatologicGastrointestinal

Uveal Melanoma, Liver Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡